Position
Fidelity in Atara Biotherapeutics, Inc.
Back to the book · All holders of ATRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $109.6K$4.73 → $11.48
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 17.2K | $310.4K | — | — | — | 0.0% |
| Q1 2026 | 16.2K | $76.8K | $4.73 | −$216.9K | −$16.6K | 0.0% |
| Q2 2026 | 16.2K | $186.4K | $11.48 | $109.6K | $0 | 0.0% |